Who owns THERIVA BIOLOGICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Theriva Biologics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Theriva Biologics stock

Who bought or sold THERIVA BIOLOGICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Ikarian Capital 120k $49k 0% Sep 2025
 View chart
Two Sigma Investments 62k $25k 100% Sep 2025
 View chart
Virtu Financial 37k $15k 7% Sep 2025
 View chart
Jane Street 37k $15k 100% Sep 2025
 View chart
Boothbay Fund Management 36k $14k 0% Sep 2025
 View chart
XTX Topco 33k $13k 91% Sep 2025
 View chart
Geode Capital Management 28k $11k 52% Sep 2025
 View chart
Two Sigma Advisers 27k $11k 100% Sep 2025
 View chart
UBS Group 23k $9.3k 2291200% Sep 2025
 View chart
Vanguard Group 16k $6.6k 100% Sep 2025
 View chart
Hrt Financial 10k $4.0k 100% Sep 2025
 View chart
BlackRock 7.5k $3.0k -1% Sep 2025
 View chart
Advisor Group Holdings 444.00 $147.985200 0% Sep 2025
 View chart
Clear Street 100.00 $43.000000 100% Jun 2025
 View chart
SBI Securities 59.00 $24.001200 -2% Sep 2025
 View chart
IFP Advisors 11.00 $3.999600 0% Sep 2025
 View chart
Sontag Advisory 2.00 $1.000000 100% Sep 2025
 View chart
Danske Bank A/s 1.00 $0 100% Sep 2025
 View chart

Who sold out of Theriva Biologics?

Fund or Company Name Date Sold Shares Held Valued At
Citadel Advisors Jun 2025 36k $16k
Two Sigma Securities Jun 2025 18k $7.7k
FMR Jun 2025 3.0k $1.3k
Pandora Wealth Jun 2025 4.00 $2.000000